These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 19388151

  • 1. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A.
    Bamford NS, White KK, Robinett SA, Otto RK, Gospe SM.
    Dev Med Child Neurol; 2009 May; 51(5):408-11. PubMed ID: 19388151
    [Abstract] [Full Text] [Related]

  • 2. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD, Sayed R, Garg M, Patil VA.
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [Abstract] [Full Text] [Related]

  • 3. Gait and footwear in children and adolescents with Charcot-Marie-Tooth disease: A cross-sectional, case-controlled study.
    Kennedy RA, McGinley JL, Paterson KL, Ryan MM, Carroll K.
    Gait Posture; 2018 May; 62():262-267. PubMed ID: 29579702
    [Abstract] [Full Text] [Related]

  • 4. Hip abnormalities in children with Charcot-Marie-Tooth disease.
    Walker JL, Nelson KR, Heavilon JA, Stevens DB, Lubicky JP, Ogden JA, VandenBrink KA.
    J Pediatr Orthop; 1994 May; 14(1):54-9. PubMed ID: 8113373
    [Abstract] [Full Text] [Related]

  • 5. Gait patterns of children and adolescents with Charcot-Marie-Tooth disease.
    Wojciechowski E, Sman A, Cornett K, Raymond J, Refshauge K, Menezes MP, Burns J, FAST Study Group.
    Gait Posture; 2017 Jul; 56():89-94. PubMed ID: 28527386
    [Abstract] [Full Text] [Related]

  • 6. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B, Pediatric Oncology Group Study.
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [Abstract] [Full Text] [Related]

  • 7. A comprehensive evaluation of the variation in ankle function during gait in children and youth with Charcot-Marie-Tooth disease.
    Õunpuu S, Garibay E, Solomito M, Bell K, Pierz K, Thomson J, Acsadi G, DeLuca P.
    Gait Posture; 2013 Sep; 38(4):900-6. PubMed ID: 23702343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in walking velocity and stride parameters with age in children with Charcot-Marie-Tooth disease.
    Õunpuu S, Pierz KA, Acsadi G, Wren TAL.
    Neuromuscul Disord; 2020 Oct; 30(10):825-832. PubMed ID: 32928646
    [Abstract] [Full Text] [Related]

  • 12. Falls in paediatric Charcot-Marie-Tooth disease: a 6-month prospective cohort study.
    Kennedy RA, Carroll K, Hepworth G, Paterson KL, Ryan MM, McGinley JL.
    Arch Dis Child; 2019 Jun; 104(6):535-540. PubMed ID: 30104392
    [Abstract] [Full Text] [Related]

  • 13. Unilateral oculomotor palsy in Charcot-Marie-Tooth disease 1A (CMT 1A).
    Posa A, Emmer A, Kornhuber ME.
    Clin Neurol Neurosurg; 2017 Apr; 155():20-21. PubMed ID: 28214652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Foot drop splints improve proximal as well as distal leg control during gait in Charcot-Marie-Tooth disease.
    Ramdharry GM, Day BL, Reilly MM, Marsden JF.
    Muscle Nerve; 2012 Oct; 46(4):512-9. PubMed ID: 22987691
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E, Moroni I, Baranello G, Magro A, Marchi A, Bulgheroni S, Ferrarin M, Pareyson D.
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [Abstract] [Full Text] [Related]

  • 20. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T, Kawakami K, Kumamoto T, Tonooka S, Abe A, Hayasaka K, Okamoto Y, Kawano Y.
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.